PreprintCited by 16Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and AnimalsGenetic and phenotypic traits in livestock

Ancestry diversity in the genetic determinants of the human plasma proteome enhances identification of potential drug targets

Open access
Pozarickij, Alfred, Said, Saredo, Lin, Kuang, Morris, Sam, Edris, Ahmed, Iona, Andri, Kartsonaki, Christiana, Wright, Neil +21 more·2023·medRxiv

Abstract

The proteome is fundamental to human biology and health but little is known about ancestral diversity of its genetic determinants. In GWAS of plasma levels of 2,923 proteins in 3,974 Chinese adults, we identified pQTLs for 1,784 proteins, including 1,312 cis -pQTLs for 1,264 proteins. Fine-mapping identified 3,475 credible sets for independent pQTLs, 36% of which were distinct from those identified in European adults as assessed by three different methods. In phenome-wide MR analyses, 59 disease associations were in strong LD (r 2 >0.95) with a cis -pQTL sentinel variant, including 26 with strong evidence of colocalisation (PP.H4>0.9) and 34 not identified in previous similar European studies. Evaluation of current drug development identified 8 confirmed therapeutic targets, 8 potential repurposing targets, and 19 potential novel targets (13 not previously reported in Europeans). The findings demonstrate the importance of extending proteogenomic studies to non-European ancestry populations to identify potential novel drug targets for major diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2023.11.13.23298365

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Protein quantitative trait loci (pQTL) are commonly detected in large-scale studies.

    “Protein quantitative trait loci (pQTL), or associations between circulating protein abundances and genetic variants either within or nearby (cis-) to the protein-encoding gene or elsewhere in the genome (trans-), are commonly detected in large-scale studies1–6.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 18

  1. Ghadermarzi, S., Li, X., Li, M. & Kurgan, L. Sequence-Derived Markers of Drug Targets and Potentially Druggable Human Proteins. Front Genet 10, 1075 (2019).
  2. Katz, D. H. et al. Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer-And antibody-based methods. Sci Adv 8, 5164 (2022).
  3. Nurmohamed, N. S. et al. Targeted proteomics improves cardiovascular risk prediction in secondary prevention. Eur Heart J 43, 1569 (2022).
  4. Bretherick, A. D. et al. Linking protein to phenotype with Mendelian Randomization detects 38 proteins with causal roles in human diseases and traits. PLoS Genet 16, e1008785 (2020).
  5. Wik, L. et al. Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide Analysis. Mol Cell Proteomics 20, 100168 (2021).
  6. Sun, B. B. et al. Genetic regulation of the human plasma proteome in 54,306 UK Biobank participants. bioRxiv 20, 2022.06.17.496443 (2022).
  7. Zhou, Y. et al. TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res (2023) doi:10.1093/NAR/GKAD751. · DOI
  8. Id, E. A. K., Davis, J. W. & Degner, J. F. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. (2019) doi:10.1371/journal.pgen.1008489. · DOI · Paper page
  9. Rusina, P. V. et al. Genetic support for FDA-approved drugs over the past decade. Nat Rev Drug Discov (2023) doi:10.1038/D41573-023-00158-X. · DOI
  10. Jenei, Z. M. et al. Persistently elevated extracellular HSP70 (HSPA1A) level as an independent prognostic marker in post-cardiac-arrest patients. Cell Stress Chaperones 18, 447 (2013).
  11. Dulin, E., García-Barreno, P. & Guisasola, M. C. Genetic variations of HSPA1A, the heat shock protein levels, and risk of atherosclerosis. Cell Stress Chaperones 17, 507 (2012).
  12. Zhang, T. et al. Common Variants in NUS1 and GP2 Genes Contributed to the Risk of Gestational Diabetes Mellitus. Front Endocrinol (Lausanne) 12, 1 (2021).
  13. Ohno, H. & Hase, K. Glycoprotein 2 (GP2): Grabbing the FimH+ bacteria into M cells for mucosal immunity. Gut Microbes 1, 407 (2010).
  14. Riedel, S., Pheiffer, C., Johnson, R., Louw, J. & Muller, C. J. F. Intestinal Barrier Function and Immune Homeostasis Are Missing Links in Obesity and Type 2 Diabetes Development. Front Endocrinol (Lausanne) 12, 833544 (2022).
  15. Solomon, T. et al. Identification of Common and Rare Genetic Variation Associated With Plasma Protein Levels Using Whole-Exome Sequencing and Mass Spectrometry. Circ Genom Precis Med 11, e002170 (2018).
  16. Walters, R. G. et al. Genotyping and population characteristics of the China Kadoorie Biobank. Cell Genomics 3, 100361 (2023).
  17. Purcell, S. et al. PLINK: A Tool Set for Whole-Genome Association and Population- Based Linkage Analyses. Am J Hum Genet 81, 559 (2007).
  18. Burgess, S., Small, D. S. & Thompson, S. G. A review of instrumental variable estimators for Mendelian randomization. https://doi.org/10.1177/0962280215597579 26, 2333-2355 (2015). · DOI

Cited by

Sorted by citations

Authors
Pozarickij, A., Said, S., Lin, K., Morris, S., Edris, A., Iona, A., Kartsonaki, C., Wright, N., Yao, P., Fry, H., Chen, Y., Yang, L., Du, H., Bennett, D., Avery, D., Schmidt, D. V., Lv, J., Yu, C., Sun, D., Pei, P., Chen, J., Hill, M., Peto, R., Collins, R., Clarke, R., Li, L., Millwood, I. Y., Chen, Z., & Walters, R. G.
Affiliations
  • University of Oxford (GB)
  • Peking University (CN)
  • China National Center for Food Safety Risk Assessment (CN)
Corresponding author
  • Chen, Zhengming
  • Walters, Robin G
Venue
medRxiv
Publisher
openRxiv
Published
2023-11-13
OpenAlex
W4388627051
Cited by
16
References
6
Citations by year
2026: 7 · 2025: 6 · 2024: 3
Type
posted content
Language
en
Open access
Locations
medRxiv (acceptedVersion, cc-by)
Funders
  • GlaxoSmithKline
  • Wellcome Trust (212946/Z/18/Z, 202922/Z/16/Z, 088158/Z/09/Z, 104085/Z/14/Z)
  • Cancer Research UK (A29186, 088158/Z/09/Z, MC_UU_00017/1, 2016YFC0900500, CH/1996001/9454, C500/A16896, 212946/Z/18/Z, C16077 /A29186, 104085/Z/14/Z, 202922/Z/16/Z)
  • National Institute for Health and Care Research
  • British Heart Foundation (104085/Z/14/Z, CH/1996001/9454, 18/23/33512, 088158/Z/09/Z, C16077/A29186, 2016YFC0900500, C500/A16896, MC_UU_00017/1, 212946/Z/18/Z, 202922/Z/16/Z)
  • University of Oxford (104085/Z/14/Z, 202922/Z/16/Z, 212946/Z/18/Z, 088158/Z/09/Z)
  • National Natural Science Foundation of China (2016YFC0900500, 104085/Z/14/Z, 212946/Z/18/Z, 202922/Z/16/Z, 088158/Z/09/Z, 82192904, C500/A16896, 82192901, C16077/A29186, MC_UU_00017/1, CH/1996001/9454, 82192900)
  • Novo Nordisk
  • Chinese Center for Disease Control and Prevention
  • Centers for Disease Control and Prevention
  • Medical Research Council (MC_UU_00017/1, MC_PC_13049, C500/A16896, 2016YFC0900500, MC_PC_14135, 104085/Z/14/Z, CH/1996001/9454, 088158/Z/09/Z, 212946/Z/18/Z, 202922/Z/16/Z, MC_U137686851, MC_UU_12026/2, C16077/A29186)
  • National Key Research and Development Program of China (MC_UU_00017/1, 088158/Z/09/Z, 2016YFC0900500, 202922/Z/16/Z, 104085/Z/14/Z, CH/1996001/9454, C16077/A29186, 212946/Z/18/Z, C500/A16896)
  • Biomedical Research Council
  • Health Data Research UK
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and phenotypic traits in livestock
Keywords
plasma proteome, protein quantitative trait loci, cis-pQTL, ancestry diversity, Chinese population, non-European ancestry, fine mapping, phenome-wide Mendelian randomization, drug target identification, drug repurposing, colocalization, proteogenomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review